レポートナンバー 0000040257
														
														
								
				ドイツのがん診断市場セグメンテーション分析(2024-2029)- がん遺伝子、生化学マーカー、リンフォカイン、GF、CSF、ホルモン、免疫組織化学的染色 - 競合分析、新興技術、最新の器具、成長機会
				VPGMarketResearch
				
				
				2024-2029 Germany Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportunities
				
					発刊日
											2024/11/25
										言語英語
					体裁PDF
				 
			 
			
			
			
			※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
			
							
			
			
							レポート概要
				
	このレポートはセクション、市場セグメントごとに提供されており、特定の情報ニーズや予算に合わせてカスタマイズできます。
	この最新レポートは、今後5年間のドイツのがん診断市場に出現する主要なビジネスチャンスに関する調査に基づいています。本レポートでは、ドイツ市場の動向を調査し、現在のアッセイと新たなアッセイをレビューし、新たな診断技術の潜在的な用途を分析し、主要な腫瘍マーカーの国別および市場セグメント別の売上を予測し、主要企業および潜在的な市場参入企業をプロファイルし、サプライヤーの具体的なビジネスチャンスを特定しています。
	論理的根拠
	研究者たちが腫瘍の診断と治療における大きな技術的ブレークスルーに近づき、新たな特異的抗原を発見し、病気の遺伝的基盤の謎を解き明かすにつれて、がん診断薬市場は爆発的な成長を遂げようとしています。今後5年間、ドイツのがん診断市場はエキサイティングでダイナミック、かつ急速に拡大する分野となることが期待されています。予想される技術的飛躍的進歩により、遺伝的素因の決定、特定の腫瘍の検出、がん治療に対する生物学的反応のモニタリングなど、多くの機会が創出されるでしょう。老年人口の増加は、悪性腫瘍アッセイに対する需要の増大と市場の急速な拡大をさらに促進するでしょう。
	ドイツ市場の概要
	- 5年間の検査量と販売予測
 
	- 
		市場力学、構造、規模、成長、主要サプライヤーのレビューを含む、包括的な市場セグメンテーション分析
	
 
	- がん診断検査を実施する検査施設の推定ユニバース
 
	- ドイツにおけるがんの統計、病因、および最近の動向
 
	ビジネスチャンスと戦略的提言
	- 今後5年間に市場に大きな魅力をもたらす可能性がある特定の新製品開発の機会
 
	- 新製品の設計基準
 
	- 代替の市場浸透戦略
 
	- 潜在的な市場参入障壁とリスク
 
	200を超える現在および新興のがん診断検査
	- がん遺伝子
 
	- 生化学マーカー
 
	- 成長因子
 
	- コロニー刺激因子
 
	- ホルモン
 
	- 免疫組織化学的染色
 
	- リンフォカイン
 
	サプライヤーのシェア、売上高および検査量の予測
	- 主要ながん診断製品サプライヤーの個別検査別の売上高と市場シェア
 
	- 
		以下の市場セグメント別の主要な腫瘍マーカーの5年間の検査量と売上予測
		➣ 病院
		➣ 商業/民間研究所
		➣ 医院・グループ診療
	 
	計測器のレビュー
	- がん検査に使用される主な分子診断装置、免疫診断装置の動作特性、機能、販売価格などの分析
 
	技術評価
	- 最新技術とその潜在的ながん診断検査への応用の評価
 
	- 競合/補完する技術のレビュー
 
	- 新しいがん診断検査および検出技術を開発している企業、大学、研究センターの広範なリスト
 
	競争戦略
	- 
		革新的ながん診断技術および製品を開発している主要なサプライヤーおよび新興企業の戦略的評価(販売、製品ポートフォリオ、マーケティング戦術、協力体制、研究開発における新製品を含む)
	
 
								レポート詳細
									
						目次
						
	Table of Contents
	
	I. Introduction
	II. Worldwide Market Overview
	III. Major Product Development Opportunities
	A. Reagent Kits and Test Systems/Panels
	B. Instrumentation
	C. Computers, Software and Automation
	D. Auxiliary Products
	IV. Design Criteria for Decentralized Testing Products
	V. Alternative Market Penetration Strategies
	A. Internal Development
	B. Collaborative Arrangements
	C. University Contracts
	D. Distribution Strategies
	VI. Potential Market Entry Barriers and Risks
	A. Market Maturity
	B. Cost Containment
	C. Competition
	D. Technological Edge and Limitations
	E. Patent Protection
	F. Regulatory Constraints
	G. Decentralized Testing Market Challenges
	VII. Worldwide Market and Technology Overview
	A. Cancer Statistics and Etiology
	1. Breast Cancer
	2. Lung Cancer
	3. Colon and Rectum Cancer
	4. Prostate Cancer
	5. Stomach Cancer
	6. Leukemia
	7. Lymphoma
	8. Oral Cancer
	9. Skin Cancer
	10. Uterine Cancer
	11. Ovarian Cancer
	12. Bladder Cancer
	B. Major Current and Emerging Cancer Diagnostic Tests
	1. Introduction
	2. Tumor Marker Classification
	3. ACTH
	4. Alpha-Fetoprotein (AFP)
	5. Beta-2 Microglobulin
	6. CA 15-3/27.29
	7. CA 19-9
	8. CA-125
	9. Calcitonin
	10. Carcinoembrionic Antigen (CEA)
	11. Estrogen and Progesterone Receptors
	12. Ferritin
	13. Gastrin
	14. Human Chorionic Gonadotropin (HCG)
	15. Insulin
	16. NSE
	17. Occult Blood
	18. PAP Smear/HPV
	19. Prostatic Acid Phosphatase (PAP)
	20. Prostate-Specific Antigen (PSA)
	21. Squamous Cell Carcinoma Antigen (SCC)
	22. T and B Lymphocytes
	23. TdT
	24. Thyroglobulin
	25. Tissue Polypeptide Antigen (TPA)
	26. Biochemical Tumor Markers
	27. Oncogenes
	- Abl/abl-bcr
	- AIB1
	- BCL-2
	- BRCA1
	- CD44
	- C-fos
	- C-myb
	- C-myc
	- CYP-17
	- Erb-B
	- HPC1
	- N-myc
	- P40
	- P51
	- P53
	- PIK3CA
	- PTI-1
	- Ras
	- Reg
	- Sis
	- Src and others
	28. Polypeptide Growth Factors
	- Basic Fibroblast Growth Factor
	- Beta-TGF
	- Cachectin (TNT)
	- Calmodulin
	- ECFR
	- Nerve Growth Factor (NGF)
	- Epidermal Growth Factor (EGF)
	- Ornithine Decarboxylase
	- Transferrin
	- Transforming Growth Factor-Alpha
	29. Ectopic Hormones
	30. Colony Stimulating Factors
	31. Lymphokines
	- Alpha-Interferon
	- B Cell Growth Factors
	- B Cell Growth Factor (BCGF)
	- Gamma-Interferon
	- Interleukin-1 (IL-1)
	- Macrophage Activating Factor
	32. Immunohistochemical Stains
	33. Emerging Tumor Markers
	- N-Acetylglucosamine
	- Actin
	- Alpha-Actin
	- Antineuronal Antibodies
	- 7B2
	- B72.3
	- Bax
	- BCD-F9
	- BLCA-4
	- Blood Group Antigens A,B,H
	- CA 50
	- CA 72-4/TAG-72
	- CA 195
	- CA-242
	- CA-549
	- CAM 26
	- CAR-3
	- Cathepsin-D
	- Chromogranin A and B
	- Cluster 1 Antigen
	- Cluster-5/5A Antigen
	- CTA
	- CU18
	- DR-70
	- DU-PAN-2
	- Endometrial Bleeding Associated Factor
	- Endostatin
	- Epithelial Membrane Antigen
	- Feulgen Hydrolysis
	- Fibronectin
	- FSH
	- (1->3)-L-fucosyltransferase
	- Gastrin-Releasing Peptide (GRP)
	- GDCFP-15
	- Glucagon
	- Glycoamines
	- H23
	- Her-2
	- Human Carcinoma Antigen
	- HPA
	- HSP27
	- Intermediate Filaments
	- Cytokeratins/CK18/Cyfra 21-1
	- Desmin
	- Gliofibrillary Acid Protein
	- Neurofilaments
	- Vimentin
	- KA 93
	- Kinases
	- KP16D3
	- LAI
	- Leukocyte Common Antigen
	- Lewis Antigens
	- Lysophosphatidic Acid (LPA)
	- Ma 695/Ma 552
	- MABDF3
	- MAG
	- ME1
	- Minactivin
	- MN/CA9
	- MSA
	- Mucin Cancer Antigen (MCA)
	- Multiple Tumor Suppressor 1
	- Myosin
	- NEA-130
	- NMP22
	- OA-519
	- Opioid Peptides
	- P-glycoprotein
	- Pancreatic Oncofetal Antigen (POA)
	- Placental Lactogen
	- PR92
	- Proliferative Index, Ki-67
	- Px
	- RB Inactivation/Deletion
	- Ret
	- SCCL 175
	- Selectin
	- Sialic Acid
	- Sialyl SSEA-1/SLX
	- SN10
	- Somatostatin
	- TA-90
	- TABA
	- Tachykinin
	- TAG 12
	- TPS
	- Troponin
	- Tubulin
	- VCAM
	- VEGF
	- Villen and others
	C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
	D. Current and Emerging Cancer Diagnostic Technologies
	1. Monoclonal and Polyclonal Antibodies
	2. Immunoassays
	3. Molecular Diagnostics
	4. Chromosome Analysis
	a. Chronic Myelogenous Leukemia (CML)
	b. Acute Myeloid Leukemia (AML)
	c. Acute Lymphoblastic Leukemia (ALL)
	d. Malignant Lymphomas Lymphoid Malignancies
	e. Chronic Lymphocytic Leukemia (CLL)
	f. Solid Cancers
	g. Chromosomal Translocation and Oncogenes
	5. Artificial Intelligence
	6. Flow Cytometry
	7. Two Dimensional Gel Electrophoresis (2-DGE)
	8. Biosensors
	9. Competing/Complementing Technologies
	E. Personal Testing
	VIII. Country Analysis
	A. Executive Summary
	B. Business Environment
	C. Market Structure
	D. Market Dynamics, Trends, Size and Growth
	- Volume Forecasts by Test and Market Segment
	- Sales Forecasts by Test and Market Segment
	- Major Supplier Sales and Market Shares
	IX. Competitive Profiles
	The report provides strategic assessments of over 30 leading cancer diagnostics market players
	and start-up companies with innovative technologies and products, including:
	- Abbott
	- Affymetrix
	- Beckman Coulter/Danaher/Cepheid
	- Becton Dickinson
	- bioMerieux
	- Bio-Rad
	- DiaSorin
	- Eiken Chemical
	- Elitech Group
	- Enzo Biochem
	- Fujifilm Wako
	- Fujirebio
	- Grifols
	- Hologic
	- Leica Biosystems
	- PerkinElmer
	- Qiagen
	- QuidelOrtho
	- Roche
	- Siemens Healthineers
	- Takara Bio
	- Thermo Fisher and others.
	List of Tables
	
	Tumor Marker Classification
	Major Companies Developing or Marketing
	ACTH Tests
	Major Companies Developing or Marketing
	AFP Tests
	Major Companies Developing or Marketing
	Beta-2 Microglobulin Tests
	Major Companies Developing or Marketing
	CA 15-3/27.29 Tests
	Major Companies Developing or Marketing
	CA 19-9 Tests
	Major Companies Developing or Marketing
	CA 125 Tests
	Major Companies Developing or Marketing
	Calcitonin Tests
	Major Companies Developing or Marketing
	CEA Tests
	Major Companies Developing or Marketing
	Estrogen Receptor Tests
	Major Companies Developing or Marketing
	Progesterone Receptor Tests
	Major Companies Developing or Marketing
	Ferritin Tests
	Major Companies Developing or Marketing
	Gastrin Tests
	Major Companies Developing or Marketing
	HCG Tests
	Major Companies Developing or Marketing
	Insulin Tests
	Major Companies Developing or Marketing
	NSE Tests
	Major Companies Developing or Marketing
	Occult Blood Tests
	Major Companies Developing or Marketing
	PAP Smear/HPV Tests
	Major Companies Developing or Marketing
	PAP Tests
	Major Companies Developing or Marketing
	PSA Tests
	Major Companies Developing or Marketing
	Lymphocyte Subclassification Tests
	Biochemical Markers Potential Applications
	In Cancer Diagnosis
	Oncogenes Potential Applications
	In Cancer Diagnosis
	Major Companies Developing or Marketing
	Oncogene Tests
	Growth Factors Potential Applications
	In Cancer Diagnosis
	Colony Stimulating Factors Potential
	Applications in Cancer Diagnosis
	Lymphokines Potential Applications In Cancer Diagnosis
	Immunohistochemical Stains Potential
	Applications in Cancer Diagnosis
	Executive Summary Table: Germany, Total Tumor
	Marker Test Volume and Sales Forecast By Market
	Segment
	Germany, Laboratories Performing Tumor
	Marker Tests by Market Segment
	Germany, Hospital Laboratories Performing
	Tumor Marker Tests by Bed Size
	Germany, Commercial/Private Laboratories
	Performing Tumor Markers by Annual
	Test Volume
	Germany, Total Tumor Marker Test Volume
	Forecast by Market Segment
	Germany, All Market Segments, Major Tumor
	Marker Test Volume Forecast
	Germany, Hospital Laboratories, Major
	Tumor Marker Test Volume Forecast by Test
	Germany, Commercial/Private Laboratories
	Major Tumor Marker Test Volume Forecast
	Germany, Physician Offices/Group
	Practices Major Tumor Marker
	Test Volume Forecast
	Germany, Total Tumor Marker Sales
	Forecast by Market Segment
	Germany, All Market Segments Major Tumor
	Marker Sales Forecast by Test
	Germany, Hospital Laboratories, Major Tumor
	Marker Sales Forecast by Test
	Germany, Commercial/Private Laboratories
	Major Tumor Marker Sales Forecast by Test
	Germany, Physician Offices/Group Practices
	Major Tumor Marker Sales Forecast by Test
	Germany, Total Tumor Marker Sales
	By Major Supplier
	Germany, AFP Testing Market Diagnostics
	Sales by Major Supplier
	Germany CA 15-3/27.29 Testing Market
	Diagnostics Sales by Major Supplier
	Germany CA 19-9 Testing Market Diagnostics
	Sales by Major Supplier
	Germany, CA 125 Testing Market Diagnostics
	Sales by Major Supplier
	Germany, CEA Testing Market Diagnostics
	Sales by Major Supplier
	Germany, PSA Testing Market Diagnostics
	Sales by Major Supplier